Recall Register

Food, drugs, devices › Spacelabs Healthcare Inc

Device recall: Xhibit Central Station, Model 96102. Intended use is to provide clinicians with central monitoring of adult, pediatric a

FDA enforcement event 75477 · Class II · initiated 18 Oct 2016 · status Terminated · terminated 3 Apr 2017

DeviceVoluntary: Firm initiated1 product recordSnoqualmie, WA

FDA enforcement event 75477 is a device recall by Spacelabs Healthcare Inc of Snoqualmie, WA, initiated 18 Oct 2016 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,232 device enforcement events initiated in 2016 carry the same class.

Status: Terminated, terminated 3 Apr 2017. Initiation: voluntary: firm initiated. Spacelabs Healthcare Inc has 27 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Spacelabs Healthcare Inc, Snoqualmie, WA.

Reason for recall

"The firm received reports of telemetry SpO2 numerics dropping off the Xhibit Central display. Desaturation, high, and low limit alarms work normally."

Distribution

"Worldwide Distribution -- USA, to AL, CA, CT, FL, GA, IA, ID, IL, IN, KY, MI, MN, MS, NC, NE, NJ, NY, OH, OK, PA, RI, SC, SD, TX, VA, WA, WY, and Puerto Rico; and, to the countries of AUSTRALIA,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0332-2017Xhibit Central Station, Model 96102. Intended use is to provide clinicians with central monitoring of adult, pediatric and neonatal patient data of patients connected to networked Spacelabs Healthcare patient monitors and telemetry transmitters.348 units (292 units in the US and 56 units outside the US)Class IITerminated9 Nov 2016

Context

91%of 2016 device events are Class II1,232 events that year
1product record in this eventfirm median: 1
27events on this register for the firm

Other enforcement events for Spacelabs Healthcare Inc

InitiatedProduct (first record)TypeClassRecords
4 Jun 2026Brand Name: Xhibit Product Name: Xhibit Central Station Model/Catalog Number: 96102 Software Version: N/A Product DescriDeviceClass II1
26 Mar 2026Brand Name: Spacelabs Ultraview SL Command Module Product Name: SL Command Module Model/Catalog Number: 91496 Software VDeviceClass II1
27 Feb 2026Multi-parameter Command Module, Model 91496, optioned with Masimo or NellcorDeviceClass II1
5 Sep 2025Brand Name: Branding is not applied to this product. Product Name: DVI display cables Model/Catalog Number: 012-0895-01 DeviceClass II3
25 Nov 2024Xhibit Telemetry Receiver with Software, Model 96280. Intended to provide monitoring system with patient data.DeviceClass II1
25 Nov 2024Xhibit Telemetry Receiver, Model 96280, with Service Manual. Intended to provide monitoring system with patient data.DeviceClass II1
12 Apr 2023Ultraview SL (UVSL) Command Module, Model 91496DeviceClass II1
31 May 2022Xhibit Telemetry Receiver, Model: 96280DeviceClass II1
30 Aug 2019Xhibit Central, Model No. 96102 - Product Usage: intended use is to provide clinicians with central monitoring of adult,DeviceClass II1
28 Jan 2019Spacelabs Healthcare Smart Disclosure System, Model 92810, a component of the Intesys Clinical Suite (ICS) G2.DeviceClass II1

All 27 events for Spacelabs Healthcare Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The firm received reports of telemetry SpO2 numerics dropping off the Xhibit Central display. Desaturation, high, and low limit alarms work normally."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution -- USA, to AL, CA, CT, FL, GA, IA, ID, IL, IN, KY, MI, MN, MS, NC, NE, NJ, NY, OH, OK, PA, RI, SC, SD, TX, VA, WA, WY, and Puerto Rico; and, to the countries of AUSTRALIA,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 3 Apr 2017. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.